Kernex Microsystems gains order worth Rs 151 crore from West Central Railways
According to the company's exchange filing, the project has a completion timeline of 600 days and will cover sections including Itarsi (Excl.)–Khandwa (Excl.) and Bina (Excl.)–Ruthiyai , among others in the Bhopal Division.
This latest win takes Kernex's cumulative KAVACH order book—including consortium and joint venture partners—since April 1, 2024, to ₹3,136.53 crore. The order underscores the growing adoption of KAVACH, the Indian Railways' indigenous train collision avoidance system, across the network as part of its safety and modernisation drive.
Kernex, which specialises in railway signalling and safety solutions, has been a key beneficiary of the government's focus on deploying KAVACH across high-density routes. With this contract, the company has further strengthened its execution pipeline, which now spans several zones of Indian Railways.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Fortis Healthcare signs O&M pact with Ekana Group for 550-bed super specialty hospital in Lucknow
By Aditya Bhagchandani Published on August 20, 2025, 22:29 IST Fortis Healthcare Ltd. on Wednesday announced that it has entered into an operations and management (O&M) agreement with Lucknow-based Ekana Group to run a 550-bed greenfield super specialty hospital coming up near Gomti Nagar, Lucknow. Once operational, the hospital will be positioned as a Centre of Excellence for tertiary care services, bringing advanced medical infrastructure and global best practices to Uttar Pradesh's capital. This marks Fortis Healthcare's third major presence in the state, after its facilities in Noida and Greater Noida. Dr. Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare, said the collaboration is a key step in strengthening the company's footprint: 'Once operational, this new 550-bed super-specialty hospital near Gomti Nagar will significantly enhance access to advanced medical care for the city and its surrounding regions. It underscores our steadfast commitment to expanding high-quality healthcare across the state.' Uday Sinha, promoter of Ekana Group, added: 'We are happy to join hands with one of India's leading healthcare chains to develop a cutting-edge tertiary care hospital, one that will deliver patient care where it's most needed.' Fortis Healthcare currently operates 33 facilities across 11 states with more than 5,700 operational beds, including O&M beds, and a network of over 400 diagnostics labs Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
an hour ago
- Business Upturn
Ajanta Pharma confirms IT raid reports, says business operations remain unaffected
By Aditya Bhagchandani Published on August 20, 2025, 22:14 IST Shares of Ajanta Pharma Ltd. declined nearly 3% on Tuesday, August 19, after reports surfaced of Income Tax department raids at the company's premises. Business Upturn first reported the development, triggering investor concerns and a knee-jerk reaction in the stock. In a regulatory filing on Wednesday, August 20, the company confirmed that the Income Tax Department had conducted a search under the Income Tax Act, 1961, at some of its offices and manufacturing units on August 19. Ajanta Pharma stated that the search was still ongoing and that it was 'fully co-operating with the officials and providing the clarifications and details sought by them.' Importantly, the company clarified that its business operations remained unaffected and continued as usual despite the search. Ajanta also denied rumours circulating on social media, attributing the recent sharp price movement in its stock purely to market-driven factors. This remains a developing story, with investors awaiting further clarity from both the company and the tax department. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
an hour ago
- Business Upturn
AGI Greenpac receives Rs 40.61 crore demand notice from Telangana power utility
By Aditya Bhagchandani Published on August 20, 2025, 22:17 IST Shares of AGI Greenpac Ltd. will be in focus after the company disclosed that it has received a demand notice of ₹40.61 crore from the Southern Power Distribution Company of Telangana Limited (TGSPDCL). According to the company's filing, the demand pertains to surplus power procured from Andhra Pradesh Gas Power Corporation Ltd. (APGPCL) between 2002 and 2022, in addition to contracted supply. AGI Greenpac, being a beneficial shareholder under a group captive power arrangement, said it had directly paid APGPCL for the surplus power at applicable rates. However, TGSPDCL issued the demand without accounting for the payments already made to APGPCL. Challenging the demand, AGI Greenpac has filed a Special Leave Petition (SLP) before the Supreme Court, which has admitted the matter and is currently hearing the case. The company said it remains confident of its position and has termed the demand 'disputed.' Investors will be watching closely for the court's outcome, as the financial impact of the demand could be material if upheld. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
